Abstract:BACKGROUND/PURPOSE: The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpressed in the most frequently occurring malignant tumors and plays a major role in the progression and angiogenesis of a number of malignancies. Recently, phage display has become widely used for many applications, including ligand generation for targeted imaging, drug delivery and therapy. In this work, we developed a panning procedure using a phage display peptide library to select a peptide that specifically binds to the VPAC1 receptor to develop a novel targeted probe for molecular imaging and therapy. METHODS: CHO-K1 cells stably expressing VPAC1 receptors (CHO-K1/VPAC1 cells) were used to select a VPAC1-binding peptide from a 12-mer phage peptide library. DNA sequencing and homologous analysis of the randomly selected phage clones were performed. A cellular ELISA was used to determine the most selectively binding peptide for further investigation. Binding specificity to the VPAC1 receptor was analyzed by competitive inhibition ELISA and flow cytometry. The binding ability of the selected peptide to CHO-K1/VPAC1 cells and colorectal cancer (CRC) cell lines was confirmed using fluorescence microscopy and flow cytometry. RESULTS: A significant enrichment of phages that specifically bound to CHO-K1/VPAC1 cells was obtained after four rounds of panning. Of the selected phage clones, 16 out of 60 shared the same peptide sequence, GFRFGALHEYNS, which we termed the VP2 peptide. VP2 and vasoactive intestinal peptide (VIP) competitively bound to the VPAC1 receptor. More importantly, we confirmed that VP2 specifically bound to CHO-K1/VPAC1 cells and several CRC cell lines. CONCLUSION: Our results demonstrate that the VP2 peptide could specifically bind to VPAC1 receptor and several CRC cell lines. And VP2 peptide may be a potential candidate to be developed as a useful diagnostic molecular imaging probe for early detection of CRC.

Searching for the Peptide Ligands of Β1-Adrenergic Receptor from Phage-Displayed Peptide Library

Screening and Identification of A Targeting Peptide to Nglp-1r from Phage Display Peptide Library

Tetrapeptide Ligands Screening for Antibody Separation and Purification by Molecular Simulation and Experimental Verification

Selection of Peptide Ligands Binding to Fibroblast Growth Factor from A Phage Peptide Library

Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors

The Improvement in Screening for Vascular Endothe Lial Growth Factor Receptor Flt-1 Antagonists in a Phage Display Library

Selection and Characterization of Chymotrypsin Peptide Inhibitors

Screening of a Specific Peptide Binding to VPAC1 Receptor from a Phage Display Peptide Library.

Modification of phage display technique for improved screening of high-affinity binding peptides

Selection of the Peptides Binding to ICAM-1 from Phage Display Random 15mer Peptide Library

Screening of Phage Displayed Random Dodecapeptide Library for Mimicking Epitopes by Anti-TNF-α Monoclonal Antibody

Screening of specific binding peptide for β-lactoglobulin using phage display technology

Selection of Trypsin Inhibitors in Phage Peptide Library

Selection of Peptide Ligands That Bind to Acid Fibroblast Growth Factor

A Novel Strategy for Proteome-wide Ligand Screening Using Cross-linked Phage Matrices

Screening of IL-2Rα Mimotope from Phage Display Peptide Library

Identifying Peptides That Specifically Bind to MDA-MB-468 Breast Cancer Cells*

Screening of Conjugated Peptide of Ouabain from Phage Display Peptide Library

Selection of Peptide Ligands Binding to Fibroblast Growth Factor Receptor 1.

A Single-Chain Fv Antibody Against Platelet Membrane Glycoprotein Ⅱb/Ⅲa Obtained Using Phage Display Technology

Identification of peptide mimetics of xenoreactive alpha-Gal antigenic epitope by phage display.